Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Current Leases (2023 - 2025)

Compass Therapeutics (CMPX) has disclosed Current Leases for 3 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 195.86% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, up 195.86% year-over-year, with the annual reading at $1.0 million for FY2025, 195.86% up from the prior year.
  • Current Leases hit $1.0 million in Q4 2025 for Compass Therapeutics, roughly flat from $1.0 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.2 million in Q1 2024 to a low of $109000.0 in Q1 2025.
  • Historically, Current Leases has averaged $852250.0 across 3 years, with a median of $1.0 million in 2024.
  • Biggest YoY gain for Current Leases was 195.86% in 2025; the steepest drop was 91.09% in 2025.
  • Year by year, Current Leases stood at $1.2 million in 2023, then plummeted by 71.76% to $338000.0 in 2024, then skyrocketed by 195.86% to $1.0 million in 2025.
  • Business Quant data shows Current Leases for CMPX at $1.0 million in Q4 2025, $1.0 million in Q3 2025, and $271000.0 in Q2 2025.